Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis ; volume:13 ; number:1 ; day:25 ; month:3 ; year:2012 ; pages:1-10 ; date:12.2012
BMC nephrology ; 13, Heft 1 (25.3.2012), 1-10, 12.2012
- Urheber
-
Takiue, Keiichi
- Beteiligte Personen und Organisationen
-
Sugiyama, Hitoshi
Inoue, Tatsuyuki
Morinaga, Hiroshi
Kikumoto, Yoko
Kitagawa, Masashi
Kitamura, Shinji
Maeshima, Yohei
Wang, Da-Hong
Masuoka, Noriyoshi
Ogino, Keiki
Makino, Hirofumi
SpringerLink (Online service)
- DOI
-
10.1186/1471-2369-13-14
- URN
-
urn:nbn:de:1111-2016081220991
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Takiue, Keiichi
- Sugiyama, Hitoshi
- Inoue, Tatsuyuki
- Morinaga, Hiroshi
- Kikumoto, Yoko
- Kitagawa, Masashi
- Kitamura, Shinji
- Maeshima, Yohei
- Wang, Da-Hong
- Masuoka, Noriyoshi
- Ogino, Keiki
- Makino, Hirofumi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy
Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis
Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss
Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes
Albuminuria
Progression of albuminuria and podocyte injury in focal segmental glomerulosclerosis inhibited by enhanced glycosphingolipid GM3 via valproic acid
Putting it mildly
Publisher Correction: Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes
De albuminuria
De albuminuria
Klinische Erfahrungen mit Adriamycin
Ergebnisse der Adriamycin-Therapie
Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy
Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis
Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss
Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes
Albuminuria
Progression of albuminuria and podocyte injury in focal segmental glomerulosclerosis inhibited by enhanced glycosphingolipid GM3 via valproic acid
Putting it mildly
Publisher Correction: Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes
De albuminuria
De albuminuria
Klinische Erfahrungen mit Adriamycin
Ergebnisse der Adriamycin-Therapie
Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy
Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis
Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss
Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes
Albuminuria
Progression of albuminuria and podocyte injury in focal segmental glomerulosclerosis inhibited by enhanced glycosphingolipid GM3 via valproic acid
Putting it mildly
Publisher Correction: Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes
De albuminuria
De albuminuria
Klinische Erfahrungen mit Adriamycin